Clinical trial
Concomitant Tarceva® and Irradiation in Patients in Local-regionally Advanced Non-small Cell Lung Cancer. A Phase II Study
NCT00888511 is registered in ClinicalTrials.gov with Olfred Hansen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concomitant Tarceva® and Irradiation in Patients in Local-regionally Advanced Non-small Cell Lung Cancer. A Phase II Study
- Lead sponsor
- Olfred Hansen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- May 31, 2016
- Enrollment
- 15 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer